Physician profile
Albert H Kwon
NPI 1942542923
$3,878.85
in general payments reported to CMS, 2019-2025
16 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,627 · 2020: $11.34 · 2021: $160 · 2022: $967 · 2023: $855 · 2024: $132 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,113.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $934.75 | 2019-2023 | Senza |
| Glaxosmithkline, LLC. | $450.21 | 2022-2023 | Shingrix |
| Abbott Laboratories | $444.17 | 2019 | |
| Boston Scientific Corporation | $323.82 | 2019-2020 | |
| Nalu Medical, INC. | $257.95 | 2021-2022 | |
| Spr Therapeutics, INC | $203.09 | 2022 | |
| Saluda Medical Americas, INC. | $193.22 | 2023 | Evoke Scs |
| Masimo Corporation | $166.90 | 2022 | |
| Relievant Medsystems, INC. | $165.39 | 2023 | Intracept |
| Mml US, INC. | $149.07 | 2023 | Reactiv8 |
| Medtronic, INC. | $133.53 | 2021-2023 | Intellis Adaptivestim |
| Biotronik Nro, INC. | $132.27 | 2024 | Prospera |
| Si-Bone, INC. | $125.38 | 2025 | |
| Avanos Medical | $99.63 | 2019 | |
| Vertiflex, INC. | $60.41 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $39.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Kwon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.